EICHOR
● Recruiting
Novel Regimens in COVID-19 Treatment
Condition: COVID · Corona Virus Infection · Sponsor: Tanta University
About this study
Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.
This description comes directly from the study's public registry record.
Talk to the study team
Sherief Abd-Elsalam, ass. prof. · 00201147773440 · sheriefabdelsalam@yahoo.com
Always discuss trial participation with your own doctor first.
Locations (2)
| Tanta University, Assiut University | Tanta, Egypt | Recruiting |
| Sherief Abd-Elsalam | Tanta, Egypt | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04382846